Labeler
Apotex Corp. NDC Codes
Apotex Corp. lists 344 finished drug products in the FDA NDC Directory under NDC labeler code 60505.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexamethasone, Lisdexamfetamine Dimesylate, Dasatinib, Brivaracetam, Ceftaroline Fosamil, Pomalidomide, Nuvigil, Eslicarbazepine Acetate, Tofacitinib, Sitagliptin, Nilotinib, Oxcarbazepine, dabigatran etexilate, Sitagliptin and Metformin Hydrochloride, Dapagliflozin
- Active ingredients
- Dexamethasone, Lisdexamfetamine dimesylate, Dasatinib, Sitagliptin phosphate, Brivaracetam, Ceftaroline fosamil, Pomalidomide, Armodafinil, Eslicarbazepine acetate, Nilotinib, Oxcarbazepine, Dabigatran etexilate mesylate
- NDC labeler codes
- 60505
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Ceftaroline fosamil 400 mg/20mL; Ceftaroline fosamil 600 mg/20mL; Eribulin mesylate .5 mg/mL; Trabectedin .05 mg/mL; Hydrocortisone sodium succinate 100 mg/2mL; Macitentan 10 mg/1; Tofacitinib 5 mg/1; Tofacitinib 10 mg/1; Tofacitinib citrate 11 mg/1; Sitagliptin phosphate 25 mg/1; Sitagliptin phosphate 100 mg/1; Metformin hydrochloride 500 mg/1; Metformin hydrochloride 1000 mg/1; Dapagliflozin 5 mg/1; Dapagliflozin 10 mg/1; Nintedanib esylate 100 mg/1; Nintedanib esylate 150 mg/1; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Kit, Injection, Powder, Lyophilized, For solution, Injection, Injection, Solution, Tablet, Extended release, Injection, Powder, For solution, Injection, Solution, Concentrate, Tablet, Film coated, Extended release, Solution/ drops, Spray, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Ophthalmic, Nasal
- Drug classes (FDA established)
- Kinase Inhibitor, Corticosteroid, Central Nervous System Stimulant, Cephalosporin Antibacterial, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Janus Kinase Inhibitor, P2Y12 Platelet Inhibitor, Anti-epileptic Agent, Direct Thrombin Inhibitor, Alkylating Drug, Biguanide, Sodium-Glucose Cotransporter 2 Inhibitor, Sympathomimetic-like Agent, Serotonin-4 Receptor Agonist, Microtubule Inhibitor, Copper Absorption Inhibitor, Platinum-based Drug, Pyridone, Endothelin Receptor Antagonist, Macrolide Antibacterial, Purine Antimetabolite, Serotonin-3 Receptor Antagonist, Factor Xa Inhibitor, Pharmacologic Cardiac Stress Test Agent, Tetracycline-class Drug, Nonsteroidal Anti-inflammatory Drug, Nucleoside Metabolic Inhibitor, Melatonin Receptor Agonist, Parathyroid Hormone Analog
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 125 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | 60505-3483 | 60505-3483-03 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | 60505-3484 | 60505-3484-03 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | 60505-3488 | 60505-3488-03 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | 60505-3489 | 60505-3489-03 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 5 mg/1; Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | 60505-3492 | 60505-3492-03 | — |
| Amlodipine and Atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | 60505-3493 | 60505-3493-03 | — |
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | 60505-3882 | 60505-3882-07 | — |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | 60505-3883 | 60505-3883-07 | — |
| Ipratropium Bromide | Ipratropium bromide 21 ug/1 | Spray, MeteredNasal | 60505-0826 | 60505-0826-01 | — |
| Ipratropium Bromide | Ipratropium bromide 42 ug/1 | Spray, MeteredNasal | 60505-0827 | 60505-0827-01 | — |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | 60505-6197 | 60505-6197-02 | — |
| Azelastine hydrochloride and Fluticasone propionate | Azelastine hydrochloride 137 ug/1; Fluticasone propionate 50 ug/1 | Spray, MeteredNasal | 60505-0953 | 60505-0953-03 | — |
| Travoprost | Travoprost .04 mg/mL | SolutionOphthalmic | 60505-0593 | 60505-0593-0160505-0593-04 | — |
| CycloSPORINE, Modfiedcyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | 60505-4630 | 60505-4630-03 | — |
| CycloSPORINE, Modfiedcyclosporine | Cyclosporine 50 mg/1 | Capsule, Liquid filledOral | 60505-4631 | 60505-4631-03 | — |
| CycloSPORINE, Modfiedcyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | 60505-4632 | 60505-4632-03 | — |
| Paroxetine Hydrochloride | Paroxetine hydrochloride 12.5 mg/1 | Tablet, Film coated, Extended releaseOral | 60505-1316 | 60505-1316-03 | — |
| Paroxetine Hydrochloride | Paroxetine hydrochloride hemihydrate 25 mg/1 | Tablet, Film coated, Extended releaseOral | 60505-1317 | 60505-1317-03 | — |
| Paroxetine Hydrochloride | Paroxetine hydrochloride hemihydrate 37.5 mg/1 | Tablet, Film coated, Extended releaseOral | 60505-1318 | 60505-1318-03 | — |
| Solifenacin Succinate | Solifenacin succinate 5 mg/1 | Tablet, Film coatedOral | 60505-4702 | 60505-4702-03 | — |
| Solifenacin Succinate | Solifenacin succinate 10 mg/1 | Tablet, Film coatedOral | 60505-4703 | 60505-4703-03 | — |
| Tigecycline | Tigecycline 50 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 60505-6098 | 60505-6098-01 | — |
| Ertapenemertapenem sodium | Ertapenem sodium 1 g/20mL | InjectionIntramuscular, Intravenous | 60505-6196 | 60505-6196-04 | — |
| Cefazolin | Cefazolin sodium 10 g/1 | Injection, Powder, For solutionIntravenous | 60505-6143 | 60505-6143-04 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, For solutionIntravenous | 60505-6156 | 60505-6156-04 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, For solutionIntravenous | 60505-6157 | 60505-6157-04 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 4 g/20mL; Tazobactam sodium .5 g/20mL | Injection, Powder, For solutionIntravenous | 60505-6159 | 60505-6159-04 | — |
| Paxilparoxetine hydrochloride | Paroxetine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 60505-4517 | 60505-4517-03 | — |
| Paxilparoxetine hydrochloride | Paroxetine hydrochloride 20 mg/1 | Tablet, Film coatedOral | 60505-4518 | 60505-4518-03 | — |
| Paxilparoxetine hydrochloride | Paroxetine hydrochloride 30 mg/1 | Tablet, Film coatedOral | 60505-4519 | 60505-4519-03 | — |
| Paxilparoxetine hydrochloride | Paroxetine hydrochloride 40 mg/1 | Tablet, Film coatedOral | 60505-4520 | 60505-4520-03 | — |
| Ofloxacin | Ofloxacin 3 mg/mL | SolutionOphthalmic | 60505-0560 | 60505-0560-0060505-0560-01 | — |
| Ceftriaxone Sodium | Ceftriaxone sodium 10 g/1 | Injection, Powder, For solutionIntravenous | 60505-6150 | 60505-6150-05 | J0696 |
| Fluticasone Propionate | Fluticasone propionate 50 ug/1 | Spray, MeteredNasal | 60505-6205 | 60505-6205-03 | — |
| Abiraterone Acetate | Abiraterone acetate 250 mg/1 | TabletOral | 60505-4327 | 60505-4327-01 | — |
| Bimatoprost | Bimatoprost .3 mg/mL | Solution/ dropsOphthalmic | 60505-0583 | 60505-0583-0160505-0583-04 | — |
| Guanfacine extended-releaseguanfacine | Guanfacine hydrochloride 1 mg/1 | Tablet, Extended releaseOral | 60505-3927 | 60505-3927-01 | — |
| Guanfacine extended-releaseguanfacine | Guanfacine hydrochloride 2 mg/1 | Tablet, Extended releaseOral | 60505-3928 | 60505-3928-01 | — |
| Guanfacine extended-releaseguanfacine | Guanfacine hydrochloride 3 mg/1 | Tablet, Extended releaseOral | 60505-3929 | 60505-3929-01 | — |
| Guanfacine extended-releaseguanfacine | Guanfacine hydrochloride 4 mg/1 | Tablet, Extended releaseOral | 60505-3930 | 60505-3930-01 | — |
| Adefovir dipivoxil | Adefovir dipivoxil 10 mg/1 | TabletOral | 60505-3947 | 60505-3947-03 | — |
| Palonosetronpalonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | 60505-6193 | 60505-6193-0160505-6193-04 | — |
| Atomoxetine Hydrochloride | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | 60505-2830 | 60505-2830-03 | — |
| Atomoxetine Hydrochloride | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | 60505-2831 | 60505-2831-03 | — |
| Atomoxetine Hydrochloride | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | 60505-2832 | 60505-2832-03 | — |
| Atomoxetine Hydrochloride | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | 60505-2833 | 60505-2833-03 | — |
| Atomoxetine Hydrochloride | Atomoxetine hydrochloride 60 mg/1 | CapsuleOral | 60505-2834 | 60505-2834-03 | — |
| Atomoxetine Hydrochloride | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | 60505-2835 | 60505-2835-03 | — |
| Atomoxetine Hydrochloride | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | 60505-2836 | 60505-2836-03 | — |
| Memantinememantine hydrochloride | Memantine hydrochloride 2 mg/mL | SolutionOral | 60505-6162 | 60505-6162-05 | — |
Apotex Corp.: common questions
- What is Apotex Corp.'s NDC labeler code?
- 60505. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Apotex Corp.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.